Martin R F, Rossi R L, Leslie K A
Lahey Clinic Medical Center, Burlington, Massachusetts, USA.
Arch Surg. 1996 Mar;131(3):247-52. doi: 10.1001/archsurg.1996.01430150025004.
To assess the long-term outcome of patients following pylorus-preserving pancreatoduodenectomy (PPPD) for chronic pancreatitis.
Retrospective study with mean follow-up of 63 months (range, 1 month to 13.7 years).
Tertiary referral hospital.
Records of all patients who underwent PPPD for chronic pancreatitis at Lahey Clinic were reviewed. All patients who were alive were contacted by telephone. In cases where patients had died, information was gathered from family members and hospital records.
Forty-five patients underwent PPPD for disabling chronic pancreatitis. The mean preoperative duration of pain was 50 months, with 32 patients (70%) requiring daily narcotics. In one patient resection of the portal vein was required. One patient died within 30 days of the operation. Forty-one patients (92%) had improvement of pain at 5 years. The mean pain score (on a scale of 0 to 10) was 9.2 preoperatively and 1.5, 0.8, 1.1, and 1.1 at 6 months, 1 year, 2 years, and 5 years, respectively. Thirty-three patients (74%) had a postoperative weight gain to an average of 92% of their pre-illness weight. New-onset diabetes occurred in six patients (14%) by 6 months and in 21 patients (46%) by 5 years. Hypoglycemia was the cause of death in one patient who underwent total pancreatectomy. Four patients died of causes unrelated to PPPD. Marginal ulcers occurred in five patients (10%). Nine patients required late operations.
In selected patients, resection of the head of the pancreas achieves long-term pain improvement in over 90% of cases. The early development of diabetes mellitus is infrequent, but over longer follow-up periods it reaches prevalence rates similar to those described in patients who have not undergone resection. Weight gain in this group was superior to that previously reported for our patients who underwent "standard Whipple" operation for chronic pancreatitis.
评估慢性胰腺炎患者行保留幽门胰十二指肠切除术(PPPD)后的长期疗效。
回顾性研究,平均随访63个月(范围1个月至13.7年)。
三级转诊医院。
回顾了在Lahey诊所接受PPPD治疗慢性胰腺炎的所有患者的记录。所有在世患者均通过电话联系。对于已死亡的患者,从其家属和医院记录中收集信息。
45例患者因致残性慢性胰腺炎接受了PPPD。术前平均疼痛持续时间为50个月,32例患者(70%)需要每日使用麻醉药品。1例患者需要切除门静脉。1例患者在术后30天内死亡。41例患者(92%)在5年时疼痛得到改善。术前平均疼痛评分(0至10分)为9.2分,在6个月、1年、2年和5年时分别为1.5分、0.8分、1.1分和1.1分。33例患者(74%)术后体重增加,平均达到患病前体重的92%。6个月时6例患者(14%)出现新发糖尿病,5年时21例患者(46%)出现新发糖尿病。1例接受全胰切除术患者因低血糖死亡。4例患者死于与PPPD无关的原因。5例患者(10%)出现边缘性溃疡。9例患者需要后期手术。
在选定患者中,胰腺头部切除术在超过90%的病例中实现了长期疼痛改善。糖尿病的早期发生并不常见,但在更长的随访期内,其患病率与未接受切除术的患者相似。该组患者的体重增加情况优于我们之前报道的接受“标准惠普尔”手术治疗慢性胰腺炎的患者。